JAK2 and essential thrombocythemia: The authors investigated the influence of the JAK2 canonical mutation in ET patients using mass spectrometry-based analysis and found that the mutation did not significantly impact the serum proteome, suggesting that its presence partially influenced the ET phenotype and that other additional factors may be involved.